JP2006523705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523705A5 JP2006523705A5 JP2006510026A JP2006510026A JP2006523705A5 JP 2006523705 A5 JP2006523705 A5 JP 2006523705A5 JP 2006510026 A JP2006510026 A JP 2006510026A JP 2006510026 A JP2006510026 A JP 2006510026A JP 2006523705 A5 JP2006523705 A5 JP 2006523705A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- aryl
- heteroaryl
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 claims 114
- 125000001424 substituent group Chemical group 0.000 claims 94
- 125000003118 aryl group Chemical group 0.000 claims 84
- 125000001072 heteroaryl group Chemical group 0.000 claims 57
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 43
- 125000005843 halogen group Chemical group 0.000 claims 38
- 229910052739 hydrogen Inorganic materials 0.000 claims 38
- 239000001257 hydrogen Substances 0.000 claims 38
- 229910052799 carbon Inorganic materials 0.000 claims 36
- 125000000623 heterocyclic group Chemical group 0.000 claims 30
- 125000000753 cycloalkyl group Chemical group 0.000 claims 27
- 150000001721 carbon Chemical group 0.000 claims 26
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 26
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 21
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 16
- 125000003545 alkoxy group Chemical group 0.000 claims 15
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 15
- 125000005129 aryl carbonyl group Chemical group 0.000 claims 15
- 150000002431 hydrogen Chemical class 0.000 claims 14
- 229910052736 halogen Inorganic materials 0.000 claims 12
- 150000002367 halogens Chemical class 0.000 claims 12
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 5
- 125000003302 alkenyloxy group Chemical group 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000003277 amino group Chemical group 0.000 claims 3
- 125000004104 aryloxy group Chemical group 0.000 claims 3
- -1 hydroxyimino Chemical group 0.000 claims 3
- 125000003367 polycyclic group Chemical group 0.000 claims 3
- 102000012479 Serine Proteases Human genes 0.000 claims 2
- 108010022999 Serine Proteases Proteins 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 125000001216 2-naphthoyl group Chemical group C1=C(C=CC2=CC=CC=C12)C(=O)* 0.000 claims 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 claims 1
- 208000006029 Cardiomegaly Diseases 0.000 claims 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 claims 1
- 206010014561 Emphysema Diseases 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 206010035664 Pneumonia Diseases 0.000 claims 1
- 206010060932 Postoperative adhesion Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 206010039085 Rhinitis allergic Diseases 0.000 claims 1
- 206010064948 Viral rhinitis Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000005277 alkyl imino group Chemical group 0.000 claims 1
- 201000010105 allergic rhinitis Diseases 0.000 claims 1
- 208000011775 arteriosclerosis disease Diseases 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 206010006451 bronchitis Diseases 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- BCAFKNBDGORVDE-UHFFFAOYSA-N n-[(5-sulfonyl-2h-thiophen-2-yl)methyl]benzamide Chemical compound C=1C=CC=CC=1C(=O)NCC1SC(=S(=O)=O)C=C1 BCAFKNBDGORVDE-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 125000000547 substituted alkyl group Chemical group 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/414,782 US7459461B2 (en) | 2001-10-19 | 2003-04-16 | Phosphonic acid compounds as inhibitors of serine proteases |
| PCT/US2004/011490 WO2004094441A2 (en) | 2003-04-16 | 2004-04-14 | Piperazine containing phosphonic acid compounds as inhibitors of serine proteases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006523705A JP2006523705A (ja) | 2006-10-19 |
| JP2006523705A5 true JP2006523705A5 (cg-RX-API-DMAC7.html) | 2007-02-22 |
| JP4526534B2 JP4526534B2 (ja) | 2010-08-18 |
Family
ID=33309497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006510026A Expired - Fee Related JP4526534B2 (ja) | 2003-04-16 | 2004-04-14 | セリンプロテアーゼのインヒビターとしての新規ホスホン酸化合物 |
Country Status (21)
| Country | Link |
|---|---|
| US (17) | US7459461B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1620446B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4526534B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101106574B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN100475824C (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004232941B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0409566A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2523203C (cg-RX-API-DMAC7.html) |
| CR (1) | CR8046A (cg-RX-API-DMAC7.html) |
| EA (1) | EA200501463A1 (cg-RX-API-DMAC7.html) |
| EC (1) | ECSP056106A (cg-RX-API-DMAC7.html) |
| ES (1) | ES2399884T3 (cg-RX-API-DMAC7.html) |
| HR (1) | HRP20050899A2 (cg-RX-API-DMAC7.html) |
| ME (1) | MEP48608A (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA05011218A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20055396L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ543139A (cg-RX-API-DMAC7.html) |
| RS (1) | RS20050778A (cg-RX-API-DMAC7.html) |
| UA (1) | UA80869C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004094441A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200509249B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459461B2 (en) * | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
| GB0224084D0 (en) | 2002-10-16 | 2002-11-27 | Glaxo Group Ltd | Novel compounds |
| GB0308333D0 (en) * | 2003-04-10 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
| US20060293298A1 (en) * | 2003-04-10 | 2006-12-28 | Bamford Mark J | Compounds |
| KR101326537B1 (ko) * | 2006-11-30 | 2013-11-08 | (주)아모레퍼시픽 | 카텝신 g 발현 억제제 조성물 |
| DK2205737T3 (da) * | 2007-10-04 | 2013-05-21 | Santaris Pharma As | Mikromirer |
| EP2058011A1 (en) * | 2007-11-07 | 2009-05-13 | Wittycell | Nkt cell activating gycolipids covalently bound antigens and/or drug |
| US8846660B2 (en) | 2009-12-25 | 2014-09-30 | Daiichi Sankyo Company, Ltd. | Seven-membered ring compound and pharmaceutical use therefor |
| US10744179B2 (en) | 2014-09-18 | 2020-08-18 | The Provost, Fellows, Foundation Scholars, & the Other Members of Board, of The College of the Holy | Method for treatment of inflammatory skin disorders with inhibitors of IL-36 proteolytic processing |
| US20260151410A1 (en) * | 2022-05-30 | 2026-06-04 | Scinnohub Pharmaceutical Co., Ltd | Tetrahydronaphthyridine Derivatives, Medicine Prepared Therefrom, and Applications Thereof in Preventing and Treating Adhesion-related Diseases |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE633914A (cg-RX-API-DMAC7.html) | 1962-06-22 | |||
| US4511551A (en) | 1982-11-18 | 1985-04-16 | Unique Technologies, Incorporated | Method and composition for the detection of a precancerous or leukemic condition in mammals |
| AT380490B (de) * | 1984-09-06 | 1986-05-26 | Voest Alpine Ag | Vorrichtung zur gewinnung der fuehlbaren waerme von schuettfaehigem heissgut |
| JPS61151199A (ja) * | 1984-12-26 | 1986-07-09 | Otsuka Pharmaceut Factory Inc | カルボン酸アミド誘導体 |
| US4704382A (en) * | 1985-07-29 | 1987-11-03 | G. D. Searle & Co. | Phenylpiperazine phosphonates |
| US4822780A (en) * | 1987-07-08 | 1989-04-18 | Otsuka Pharmaceutical Factory, Inc. | Carboxamide compounds |
| US5508273A (en) | 1993-12-30 | 1996-04-16 | Ortho Pharmaceutical Corporation | Substituted phosphonic acids and derivatives useful in treating bone wasting diseases |
| DK0871454T3 (da) | 1995-07-17 | 2004-03-22 | Cephalon Inc | Phosphorholdige inhibitorer af cystein- og serinprotease |
| US6080738A (en) * | 1996-10-25 | 2000-06-27 | Yoshitomi Pharmaceuticals Industries, Ltd. | Heterocyclic amide compounds and medicinal uses thereof |
| CN1160075C (zh) * | 1998-03-11 | 2004-08-04 | 卫福有限公司 | 杂环酰胺化合物在制备IgE抗体产生抑制剂中的用途 |
| BR0213961A (pt) | 2001-10-19 | 2004-08-31 | Ortho Mcneil Pharm Inc | Compostos de ácido fosfÈnico como inibidores de serina protease |
| US7459461B2 (en) | 2001-10-19 | 2008-12-02 | Ortho-Mcneil Pharmaceutical, Inc. | Phosphonic acid compounds as inhibitors of serine proteases |
| US20090143396A1 (en) | 2005-10-12 | 2009-06-04 | Malecha James W | Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors |
-
2003
- 2003-04-16 US US10/414,782 patent/US7459461B2/en not_active Expired - Fee Related
-
2004
- 2004-04-14 MX MXPA05011218A patent/MXPA05011218A/es unknown
- 2004-04-14 CA CA2523203A patent/CA2523203C/en not_active Expired - Fee Related
- 2004-04-14 BR BRPI0409566-9A patent/BRPI0409566A/pt not_active IP Right Cessation
- 2004-04-14 NZ NZ543139A patent/NZ543139A/en unknown
- 2004-04-14 JP JP2006510026A patent/JP4526534B2/ja not_active Expired - Fee Related
- 2004-04-14 EP EP04759852A patent/EP1620446B1/en not_active Expired - Lifetime
- 2004-04-14 UA UAA200509837A patent/UA80869C2/xx unknown
- 2004-04-14 KR KR1020057019811A patent/KR101106574B1/ko not_active Expired - Fee Related
- 2004-04-14 HR HR20050899A patent/HRP20050899A2/xx not_active Application Discontinuation
- 2004-04-14 ME MEP-486/08A patent/MEP48608A/xx unknown
- 2004-04-14 CN CNB2004800165009A patent/CN100475824C/zh not_active Expired - Fee Related
- 2004-04-14 AU AU2004232941A patent/AU2004232941B2/en not_active Ceased
- 2004-04-14 ES ES04759852T patent/ES2399884T3/es not_active Expired - Lifetime
- 2004-04-14 EA EA200501463A patent/EA200501463A1/ru unknown
- 2004-04-14 WO PCT/US2004/011490 patent/WO2004094441A2/en not_active Ceased
- 2004-04-14 RS YUP-2005/0778A patent/RS20050778A/sr unknown
-
2005
- 2005-10-14 CR CR8046A patent/CR8046A/es not_active Application Discontinuation
- 2005-10-14 EC EC2005006106A patent/ECSP056106A/es unknown
- 2005-11-15 ZA ZA200509249A patent/ZA200509249B/en unknown
- 2005-11-15 NO NO20055396A patent/NO20055396L/no not_active Application Discontinuation
-
2008
- 2008-10-24 US US12/289,000 patent/US20090118504A1/en not_active Abandoned
- 2008-10-24 US US12/288,992 patent/US20090124581A1/en not_active Abandoned
- 2008-10-24 US US12/288,999 patent/US20090118234A1/en not_active Abandoned
- 2008-10-24 US US12/288,998 patent/US8198440B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/288,941 patent/US8178673B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/290,028 patent/US8247599B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/288,920 patent/US8394804B2/en not_active Expired - Fee Related
- 2008-10-24 US US12/288,993 patent/US20090137528A1/en not_active Abandoned
- 2008-10-24 US US12/290,027 patent/US20090131671A1/en not_active Abandoned
-
2010
- 2010-12-20 US US12/973,013 patent/US8207338B2/en not_active Expired - Fee Related
- 2010-12-20 US US12/972,848 patent/US8461195B2/en not_active Expired - Fee Related
- 2010-12-20 US US12/972,744 patent/US8304430B2/en not_active Expired - Fee Related
- 2010-12-20 US US12/972,891 patent/US8212039B2/en not_active Expired - Fee Related
-
2012
- 2012-05-15 US US13/471,876 patent/US8497373B2/en not_active Expired - Fee Related
- 2012-07-17 US US13/550,963 patent/US8609888B2/en not_active Expired - Fee Related
-
2013
- 2013-06-19 US US13/921,476 patent/US8703957B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101490004B (zh) | 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烯基醇的衍生物 | |
| ES2397292T3 (es) | Nuevo derivado de indol que tiene actividad inhibidora de cinasa I B | |
| ES2563319T3 (es) | Compuestos inhibidores de metaloenzimas | |
| ES2671387T3 (es) | Compuestos inhibidores de metaloenzimas | |
| ES2624791T3 (es) | Inhibidores de PDE10 y composiciones y métodos relacionados | |
| AU2014278172B2 (en) | Metalloenzyme inhibitor compounds | |
| TW200300141A (en) | Organic compounds | |
| JP5822840B2 (ja) | 眼疾患処置薬 | |
| JP2004502756A5 (cg-RX-API-DMAC7.html) | ||
| EP4119560A1 (en) | Apoptosis-inducing agents | |
| HRP20120878T1 (hr) | Derivat 4-pirimidinsulfamida | |
| JP2008515852A5 (cg-RX-API-DMAC7.html) | ||
| EP2959903B1 (en) | Medicine for treating eye disease | |
| DE10237722A1 (de) | Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase | |
| CA3055292A1 (en) | Metalloenzyme inhibitor compounds | |
| CN101489551A (zh) | 氨基吲唑脲衍生物 | |
| WO2005092856A8 (en) | Tetrahydrocarbazoles and derivatives | |
| JP2018517693A (ja) | 選択的ヒストンデアセチラーゼ阻害剤としてのヘテロ環状アルキル誘導体化合物及びこれを含有する薬剤学的組成物 | |
| RU2008118201A (ru) | Антагонист рецептора s1p3 | |
| JP2007506692A5 (cg-RX-API-DMAC7.html) | ||
| CA2523203A1 (en) | Novel phosphonic acid compounds as inhibitors of serine proteases | |
| JP2004520438A5 (cg-RX-API-DMAC7.html) | ||
| US9388166B2 (en) | 6-aminoindole derivatives as TRP channel antagonists | |
| JP2003012667A (ja) | キノリンカルボキサミド骨格を有する抗菌剤 | |
| JP2016526563A (ja) | 肺および気道の疾患を処置するための上皮性ナトリウムチャネルの阻害剤としてのアミロライド型化合物 |